This information
collection is approved through September 30, 1995 wit the condition
that within 6 months FDA consult with OMB regarding the proposed
changesin agency testing policy with respect to insulin
certification and replicate testing of insulin batches.
Inventory as of this Action
Requested
Previously Approved
09/30/1995
09/30/1995
490
0
0
612
0
0
0
0
0
ANALYTICAL DATA PREREQUISITE FOR BATCH
CERTIFICATION WITHOUT WHICH THE BATCH CANNOT LEGALLY BE
DISTRIBUTED. PROGRAM IS MANDATED BY STATUTE AND IS SELF-SUPPORTING
THROUGH FEES.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.